Sauer Charles W, Marc-Aurele Krishelle L
Department of Pediatrics, University of California, San Diego, CA, USA.
Am J Case Rep. 2016 Jun 3;17:375-8. doi: 10.12659/ajcr.898002.
Infants born at 23 weeks' gestation have a poor prognosis and require intensive care, including blood transfusions, to survive. Generally speaking, the decision to forgo life support is acceptable. Jehovah's Witnesses believe that life is sacred and want lifesaving interventions except for blood transfusions. Therefore, an ethical dilemma exists when a baby is born on the edge of viability to parents that are Jehovah's Witnesses. In this case, if parents and healthcare professionals disagree on the best interests of the child, the medical team should obtain a court order from the state to intervene.
We present the case of an infant born at 23 weeks' gestation to parents who are Jehovah's Witnesses. The parents wanted full life-support, except for blood transfusions, to be given. The clinical team obtained a court order to transfuse the infant. The infant unfortunately died despite all efforts.
Currently, it is nearly impossible to honor the beliefs of Jehovah's Witnesses to provide lifesaving treatments without blood transfusions for infants born at the border of viability. If the goal is to prolong life, the standard of care for a premature infant is for a doctor to obtain a court order to override the beliefs and wishes of Jehovah's Witness parents and transfuse blood products as medically indicated. Although bloodless techniques for high-risk surgeries are under development, care for premature infants at 23 weeks' gestation necessitates red cell transfusions.
孕23周出生的婴儿预后较差,需要重症监护,包括输血才能存活。一般来说,放弃生命支持的决定是可以接受的。耶和华见证人认为生命是神圣的,除输血外希望采取挽救生命的干预措施。因此,当一名处于存活边缘的婴儿出生在耶和华见证人的父母身边时,就会出现伦理困境。在这种情况下,如果父母和医疗保健专业人员在孩子的最佳利益问题上存在分歧,医疗团队应从该州获得法院命令以进行干预。
我们介绍了一名孕23周出生的婴儿的病例,其父母是耶和华见证人。父母希望给予婴儿除输血外的全面生命支持。临床团队获得了法院命令为婴儿输血。尽管竭尽全力,婴儿不幸死亡。
目前,对于孕23周出生的婴儿,几乎不可能在不输血的情况下尊重耶和华见证人的信仰来提供挽救生命的治疗。如果目标是延长生命,早产婴儿的护理标准是医生获得法院命令以推翻耶和华见证父母的信仰和意愿,并根据医学指征输注血液制品。尽管针对高风险手术的无血技术正在开发中,但对孕23周的早产婴儿进行护理需要输注红细胞。